To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene PPIL4andZC3H12DTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
278 supporting clones for gene PPIL4andZC3H12D back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW504645 lymph .a 1 to 475 8 to 482   tiling clone,   475/482
(98 %)
7 diff
(98.6 %id)
TI_154160881   .a 1 to 737 73 to 815       741/743
(99 %)
29 diff
(96.1 %id)
TI_2016727785   .a 42 to 1033 1000 to 10       991/1285
(77 %)
6 diff
(99.6 %id)
TI_2016726295   .a 44 to 1085 57 to 1089     Submitted on the opposite strand 1033/1269
(81 %)
14 diff
(98.9 %id)
BC157832 Brain, cerebral cortex, PCR rescued clones .a 50 to 1929 1 to 1881 G264K N265K A266C P267T M268Y ... tiling clone,   1881/1881
(100 %)
5 diff
(99.8 %id)
TI_2016730539   .a 50 to 554 53 to 557       505/557
(90 %)
23 diff
(95.9 %id)
NM_207360.2   .a 50 to 4955 1 to 4907 G264K N265K A266C P267T M268Y ... RefSeq,   4907/4907
(100 %)
2 diff
(100.0 %id)
TI_2016730249   .a 54 to 1143 50 to 1133       1084/1265
(85 %)
47 diff
(96.3 %id)
CN285548 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 91 to 641 1 to 551   tiling clone,   551/551
(100 %)
0 diff
(100 %id)
BM152774 leukopheresis .a 113 to 476 1 to 365       365/365
(100 %)
27 diff
(92.7 %id)
BU430916 lymph .a 141 to 538 8 to 405       398/405
(98 %)
3 diff
(99.3 %id)
TI_154152645   .a 141 to 622 82 to 563       482/510
(94 %)
10 diff
(98.1 %id)
DA957330 Spleen .a 169 to 734 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
CR974993 T-Lymphocytes .a 182 to 945 1 to 765       765/765
(100 %)
2 diff
(99.8 %id)
BU430918 lymph .a 519 to 868 8 to 357       350/357
(98 %)
7 diff
(98.1 %id)
TI_154152649   .a 519 to 1029 80 to 594       515/515
(100 %)
16 diff
(96.9 %id)
BX294207   .a 666 to 888 226 to 1       226/244
(92 %)
16 diff
(93.5 %id)
TI_2016728325   .a 713 to 1894 1 to 1182       1182/1301
(90 %)
11 diff
(99.2 %id)
CR984171 T-Lymphocytes .a 1120 to 1438 1 to 319       319/322
(99 %)
3 diff
(99.1 %id)
TI_2016727247   .a 1369 to 1927 617 to 59     Submitted on the opposite strand 559/1300
(43 %)
0 diff
(100 %id)
BG397809 B-cells, primary B-cells from tonsils (cell line) .a 1730 to 2390 1 to 662   tiling clone,   662/684
(96 %)
4 diff
(99.5 %id)
AA714003 germinal center B-cells, tonsil .a 1887 to 2260 1 to 373     Submitted on the opposite strand 373/373
(100 %)
2 diff
(99.5 %id)
BF849749 lung_normal .a 1960 to 2286 5 to 331   tiling clone,   327/331
(98 %)
6 diff
(98.2 %id)
AW440017 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1987 to 2389 418 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 403/403
(100 %)
4 diff
(99.1 %id)
AW574954 lymph .a 4605 to 4957 369 to 17   tiling clone,   353/369
(95 %)
0 diff
(100 %id)
AK315388 hippocampus .b 1 to 1575 2 to 1576 exact tiling clone,   1576/1576
(100 %)
0 diff
(100 %id)
DA293855 hippocampus .b 1 to 506 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DB243702 stomach, tumor tissue .b 23 to 583 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
BP234651 coronary artery .b 55 to 636 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ429556 testis .b 56 to 657 1 to 610       610/789
(77 %)
18 diff
(97.8 %id)
BU598474 mixed (pool of 40 RNAs) .b 56 to 620 1 to 573       573/881
(65 %)
23 diff
(97.4 %id)
BC020986 Colon, adenocarcinoma .b 64 to 2103 1 to 2040 exact available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2040/2040
(100 %)
0 diff
(100 %id)
CD688747 normal nasopharynx .b 64 to 650 11 to 597       587/597
(98 %)
6 diff
(99.0 %id)
BX537536 human bone marrow .b 66 to 2287 1 to 2224 E131* tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2224/2224
(100 %)
5 diff
(99.8 %id)
BX503584   .b 66 to 654 1 to 591     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 591/591
(100 %)
4 diff
(99.4 %id)
BC107684 Duodenum, adenocarcinoma .b 66 to 1242 1 to 1177   AAA   1177/1177
(100 %)
0 diff
(100 %id)
BM562747 duodenal adenocarcinoma, cell line, small intestine .b 66 to 965 1 to 904       902/1025
(88 %)
5 diff
(99.6 %id)
AF357880   .b 67 to 2533 1 to 2467 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2467/2467
(100 %)
1 diff
(100.0 %id)
CD700888 normal nasopharynx .b 67 to 444 43 to 420       378/420
(90 %)
7 diff
(98.4 %id)
NM_139126.2   .b 67 to 2533 1 to 2467 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2467/2467
(100 %)
0 diff
(100 %id)
CD703785 normal nasopharynx .b 68 to 673 15 to 620       606/620
(97 %)
6 diff
(99.1 %id)
DA334710 hippocampus .b 69 to 572 2 to 508   capped   507/507
(100 %)
7 diff
(98.7 %id)
DB129551 thymus .b 70 to 596 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
BP372983 umbilical cord .b 70 to 648 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
CN390064 embryonic stem cells, DMSO-treated H9 cellline .b 71 to 810 1 to 740       740/749
(98 %)
6 diff
(99.2 %id)
BU599054 mixed (pool of 40 RNAs) .b 71 to 657 1 to 589       589/786
(74 %)
10 diff
(98.8 %id)
DA997828   .b 71 to 559 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
BP381097   .b 71 to 483 1 to 412       412/624
(66 %)
2 diff
(99.7 %id)
AL708845 human skeletal muscle .b 73 to 484 1 to 412       412/412
(100 %)
4 diff
(99.1 %id)
DA539697 Kidney .b 73 to 663 2 to 592   capped   591/593
(99 %)
5 diff
(99.2 %id)
BF978516 melanotic melanoma, high MDR, skin .b 73 to 757 1 to 685       684/903
(75 %)
24 diff
(97.4 %id)
BU945340 mixed (pool of 40 RNAs) .b 73 to 898 1 to 838       838/843
(99 %)
24 diff
(97.2 %id)
DA884627   .b 75 to 642 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB253139 uterus .b 75 to 655 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
CN390068 embryonic stem cells, DMSO-treated H9 cellline .b 76 to 190 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
DA032444   .b 77 to 572 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
DA346973 substantia nigra .b 77 to 603 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA408666 thalamus .b 77 to 635 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AA425562   .b 77 to 498 1 to 422     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 422/422
(100 %)
0 diff
(100 %id)
DA933076 Spleen .b 77 to 633 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
CD687518 normal nasopharynx .b 79 to 664 32 to 617       586/617
(94 %)
7 diff
(98.9 %id)
CD689478 normal nasopharynx .b 79 to 656 25 to 602       578/602
(96 %)
6 diff
(99.1 %id)
DB448423 testis .b 79 to 303 1 to 225       225/270
(83 %)
10 diff
(96.3 %id)
AL601043   .b 80 to 816 1 to 738       738/738
(100 %)
2 diff
(99.8 %id)
CN390069 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 82 to 819 18 to 755       738/755
(97 %)
7 diff
(99.1 %id)
BC064134 Uterus, leiomyosarcoma .b 82 to 1397 1 to 1316   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1316/1318
(99 %)
6 diff
(99.6 %id)
BU902652 leiomyosarcoma, uterus .b 82 to 901 46 to 875   available from MGC,   830/947
(87 %)
21 diff
(97.8 %id)
AV697975 hepatocellular carcinoma .b 92 to 724 1 to 634       634/650
(97 %)
12 diff
(98.2 %id)
CN390066 embryonic stem cells, DMSO-treated H9 cellline .b 93 to 415 1 to 323       323/323
(100 %)
2 diff
(99.4 %id)
TI_1948133419   .b 96 to 890 124 to 919       796/1358
(58 %)
34 diff
(97.5 %id)
TI_1948133420   .b 96 to 1057 127 to 1068       944/1349
(69 %)
37 diff
(97.3 %id)
TI_1948133421   .b 96 to 967 124 to 994       871/1386
(62 %)
18 diff
(98.8 %id)
TI_1948133955   .b 96 to 899 123 to 928       806/1456
(55 %)
15 diff
(99.0 %id)
TI_1948133956   .b 96 to 967 124 to 994       871/1381
(63 %)
14 diff
(99.0 %id)
TI_1948133957   .b 96 to 975 127 to 1004       878/1356
(64 %)
24 diff
(98.3 %id)
TI_1948134501   .b 96 to 899 127 to 927       801/1398
(57 %)
24 diff
(98.3 %id)
TI_1948134502   .b 96 to 1017 127 to 1044       918/1369
(67 %)
32 diff
(97.7 %id)
TI_1948134503   .b 96 to 901 126 to 938       813/1413
(57 %)
27 diff
(98.1 %id)
TI_1948135035   .b 96 to 780 130 to 814       685/1453
(47 %)
16 diff
(98.9 %id)
TI_1948135036   .b 96 to 974 132 to 1011       880/1458
(60 %)
22 diff
(98.5 %id)
TI_1948135037   .b 96 to 899 125 to 935       811/1489
(54 %)
37 diff
(97.6 %id)
BX425558 neuroblastoma .b 97 to 1175 1 to 1081       1081/1081
(100 %)
4 diff
(99.7 %id)
CN390071 embryonic stem cells, cell lines H1, H7, andH9 .b 97 to 822 1 to 725       725/725
(100 %)
3 diff
(99.6 %id)
CV023554 mixed .b 97 to 698 1 to 602       602/602
(100 %)
0 diff
(100 %id)
AI880208 brain, oligodendroglioma .b 109 to 567 1 to 459     Submitted on the opposite strand 459/459
(100 %)
0 diff
(100 %id)
BE887712 leiomyosarcoma, uterus .b 118 to 849 1 to 727       727/902
(80 %)
24 diff
(97.4 %id)
CN390065 embryonic stem cells, DMSO-treated H9 cellline .b 133 to 444 1 to 312       312/312
(100 %)
0 diff
(100 %id)
AA346646 heart .b 196 to 419 1 to 224       224/224
(100 %)
0 diff
(100 %id)
CD557673 testis .b 230 to 967 30 to 768       743/936
(79 %)
17 diff
(98.2 %id)
CN390063 embryonic stem cells, DMSO-treated H9 cellline .b 264 to 888 1 to 625       625/625
(100 %)
4 diff
(99.4 %id)
BX361449 Placenta Cot 25-normalized .b 294 to 964 230 to 896       667/992
(67 %)
31 diff
(96.9 %id)
BQ301087 bladder_tumor .b 303 to 774 473 to 1       473/473
(100 %)
5 diff
(99.0 %id)
N22655   .b 353 to 524 1 to 172       172/172
(100 %)
1 diff
(99.5 %id)
DA261106 caudate nucleus .b 364 to 922 2 to 558   capped   557/557
(100 %)
5 diff
(99.2 %id)
AW811775 stomach .b 448 to 692 1 to 247       245/247
(99 %)
6 diff
(97.6 %id)
AW811786 stomach .b 505 to 696 1 to 192       192/205
(93 %)
12 diff
(94.2 %id)
CD246003 White Matter .b 520 to 1079 9 to 567       559/915
(61 %)
8 diff
(99.2 %id)
BF362752 nervous_normal .b 545 to 975 481 to 48       434/481
(90 %)
11 diff
(97.8 %id)
TI_1948133422   .b 554 to 1574 1145 to 126       1020/1323
(77 %)
33 diff
(97.6 %id)
BU933879 mixed (pool of 40 RNAs) .b 566 to 1296 1 to 734       734/775
(94 %)
20 diff
(97.5 %id)
BG901158 cartilage .b 609 to 934 82 to 407       326/343
(95 %)
8 diff
(97.7 %id)
FN126534 breast carcinoma .b 612 to 708 1 to 95       95/96
(98 %)
3 diff
(96.9 %id)
BF670066 brain, primitive neuroectoderm .b 646 to 1233 1 to 588       588/590
(99 %)
11 diff
(98.2 %id)
BG030876 breast, mammary adenocarcinoma, cell line .b 650 to 1368 13 to 730       718/1041
(68 %)
10 diff
(99.1 %id)
TI_1948133423   .b 651 to 1574 1051 to 127       925/1332
(69 %)
16 diff
(98.8 %id)
TI_1948133958   .b 658 to 1574 1042 to 128       915/1292
(70 %)
8 diff
(99.4 %id)
TI_1948135038   .b 658 to 1574 1040 to 128       915/1293
(70 %)
9 diff
(99.4 %id)
CB045815 colon, juvenile granulosa tumor .b 661 to 1172 11 to 522       512/522
(98 %)
6 diff
(98.9 %id)
TI_1948133424   .b 663 to 1574 1049 to 128       922/1218
(75 %)
24 diff
(98.1 %id)
TI_1948133960   .b 668 to 1574 1039 to 127       911/1214
(75 %)
28 diff
(97.7 %id)
BI091006 cervix .b 683 to 1332 1 to 661       659/1011
(65 %)
28 diff
(97.3 %id)
TI_1948133959   .b 723 to 1574 982 to 127       856/1382
(61 %)
7 diff
(99.5 %id)
TI_1948134504   .b 723 to 1574 985 to 129       857/1372
(62 %)
24 diff
(98.3 %id)
BU150551 dorsal root ganglia .b 740 to 1403 1 to 671   AAA   671/855
(78 %)
18 diff
(97.9 %id)
TI_1948135039   .b 763 to 1574 937 to 122       816/1395
(58 %)
32 diff
(97.8 %id)
TI_1948134506   .b 764 to 1574 933 to 126       808/1199
(67 %)
30 diff
(97.5 %id)
BU955360 mixed (pool of 40 RNAs) .b 768 to 1077 3 to 312   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 310/339
(91 %)
4 diff
(98.9 %id)
W27229 eye, retina .b 790 to 1325 23 to 560       538/612
(87 %)
31 diff
(95.0 %id)
DW431595 Liver .b 817 to 1068 17 to 268       252/268
(94 %)
6 diff
(97.8 %id)
FN093657 breast carcinoma .b 818 to 918 1 to 99       99/99
(100 %)
2 diff
(98.0 %id)
BE174527 head_neck .b 836 to 1175 353 to 9     Submitted on the opposite strand 345/353
(97 %)
7 diff
(98.1 %id)
CN390067 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 844 to 1493 27 to 677       651/677
(96 %)
7 diff
(99.0 %id)
BF030453 hypernephroma, Kidney .b 869 to 1523 1 to 651       651/699
(93 %)
35 diff
(95.0 %id)
BG778585 adenocarcinoma, Prostate .b 896 to 1582 1 to 687       687/687
(100 %)
5 diff
(99.3 %id)
TI_1948134505   .b 898 to 1574 804 to 129       676/1287
(52 %)
21 diff
(98.4 %id)
BG459913   .b 900 to 1253 517 to 160   AAA Submitted on the opposite strand 358/446
(80 %)
7 diff
(98.5 %id)
BC016984 Bone, osteosarcoma .b 907 to 2102 1 to 1196   available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1196/1196
(100 %)
0 diff
(100 %id)
BG027339 Bone, osteosarcoma, cell line .b 907 to 1555 1 to 665   available from MGC,   665/692
(96 %)
50 diff
(92.8 %id)
BF334134 colon .b 910 to 1311 405 to 4       402/405
(99 %)
0 diff
(100 %id)
BU943056 mixed (pool of 40 RNAs) .b 922 to 1643 1 to 723       723/723
(100 %)
3 diff
(99.6 %id)
BU852119 testis .b 959 to 1757 1 to 813       813/824
(98 %)
24 diff
(97.1 %id)
BM709677 eye, Retina Foveal and Macular .b 985 to 1495 1 to 512     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 512/512
(100 %)
2 diff
(99.7 %id)
BE887609 leiomyosarcoma, uterus .b 986 to 1657 78 to 756       679/918
(73 %)
17 diff
(98.2 %id)
CV029740 mixed .b 997 to 1574 1 to 578       578/672
(86 %)
1 diff
(99.9 %id)
TI_1948089374   .b 997 to 1574 138 to 714   fully sequenced,   577/714
(80 %)
18 diff
(97.5 %id)
TI_1948089569   .b 997 to 1516 133 to 655       523/1066
(49 %)
23 diff
(97.9 %id)
TI_1948089747   .b 997 to 1522 150 to 676       527/1131
(46 %)
23 diff
(98.0 %id)
BF691981 melanotic melanoma, high MDR, skin .b 1022 to 1504 1 to 486       486/856
(56 %)
14 diff
(98.4 %id)
CD676875 eye, Trabecular meshwork .b 1033 to 1651 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
FN161246 breast carcinoma .b 1035 to 1167 1 to 137       137/138
(99 %)
5 diff
(96.4 %id)
AF068298   .b 1037 to 2169 1 to 1133       1133/1137
(99 %)
2 diff
(99.9 %id)
AA132257 colon, tumor .b 1037 to 1400 1 to 364       364/364
(100 %)
0 diff
(100 %id)
AA132362 colon, tumor .b 1037 to 1401 1 to 365       365/365
(100 %)
0 diff
(100 %id)
AW376127 colon .b 1046 to 1488 18 to 458       441/458
(96 %)
8 diff
(98.3 %id)
BG112590 Bone, osteosarcoma, cell line .b 1068 to 1590 1 to 537       537/1173
(45 %)
18 diff
(98.5 %id)
FN158767 breast carcinoma .b 1109 to 1221 1 to 111       111/114
(97 %)
3 diff
(97.4 %id)
TI_151763965   .b 1200 to 2103 990 to 95   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 896/985
(90 %)
29 diff
(97.1 %id)
BP283741 bone marrow .b 1215 to 1796 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BX361448 Placenta Cot 25-normalized .b 1219 to 2234 1013 to 1       1013/1022
(99 %)
30 diff
(97.1 %id)
TI_1948089375   .b 1235 to 1574 467 to 128   fully sequenced,   340/467
(72 %)
1 diff
(99.8 %id)
AW377734 head_neck .b 1271 to 1372 103 to 1       103/103
(100 %)
1 diff
(99.1 %id)
BQ719311 sympathetic trunk .b 1283 to 2006 1 to 728       728/962
(75 %)
7 diff
(99.3 %id)
BQ373454 prostate_tumor .b 1296 to 1531 1 to 234       234/249
(93 %)
8 diff
(96.8 %id)
BM759666 stomach .b 1299 to 1550 1 to 252       252/252
(100 %)
0 diff
(100 %id)
BM757769 stomach .b 1299 to 1553 1 to 255       255/255
(100 %)
0 diff
(100 %id)
BM833090 stomach .b 1299 to 1642 1 to 344       344/344
(100 %)
1 diff
(99.8 %id)
BX503585   .b 1751 to 2287 567 to 31   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 537/537
(100 %)
1 diff
(99.9 %id)
AA425357   .b 1758 to 2108 362 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 352/352
(100 %)
1 diff
(99.8 %id)
AA132258 colon, tumor .b 1790 to 2182 398 to 6       393/402
(97 %)
0 diff
(100 %id)
BU734171 eye, Retina Foveal and Macular .b 1860 to 2179 338 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 320/320
(100 %)
2 diff
(99.4 %id)
AK092069   .c 1 to 3306 2 to 3308 exact tiling clone, available from FLJ,   3308/3308
(100 %)
3 diff
(100.0 %id)
AX747342   .c 1 to 3306 2 to 3308 exact     3308/3308
(100 %)
3 diff
(100.0 %id)
DA654453   .c 1 to 505 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
DB321775   .c 2788 to 3306 519 to 1       519/519
(100 %)
2 diff
(99.7 %id)
AK090441 Spleen .d-u 1 to 5542 1 to 5557 V15A G145R R146P V147G P148A ... tiling clone, available from FLJ,   5557/5557
(100 %)
23 diff
(99.6 %id)
AA837405 germinal center B cell .d-u 633 to 1072 449 to 9   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 441/449
(98 %)
0 diff
(100 %id)
BX294202   .d-u 670 to 1207 547 to 1       547/1005
(54 %)
20 diff
(98.1 %id)
BF975976 B-cells, primary B-cells from tonsils (cell line) .d-u 4646 to 5426 1 to 765   tiling clone,   765/894
(85 %)
33 diff
(96.4 %id)
BG958144 colon .d-u 5087 to 5540 1 to 454       454/454
(100 %)
16 diff
(96.5 %id)
AI697060 colon .d-u 5094 to 5541 453 to 6   tiling clone,   448/453
(98 %)
0 diff
(100 %id)
TI_154132367   .d-u 5148 to 5543 450 to 55       396/1262
(31 %)
0 diff
(100 %id)
BX090379 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d-u 5226 to 5543 331 to 14       318/331
(96 %)
0 diff
(100 %id)
AV712608   .d-u 5227 to 5547 1 to 321   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 321/321
(100 %)
0 diff
(100 %id)
AI619720 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d-u 5263 to 5543 299 to 19       281/299
(93 %)
0 diff
(100 %id)
BC127762 PCR rescued clones, C list .e 1 to 758 1 to 758 exact tiling clone,   758/758
(100 %)
0 diff
(100 %id)
CF993896 Human Placenta, placenta .f 1 to 731 22 to 754 V133C P134S S135I W136L R137E ... tiling clone,   733/834
(87 %)
16 diff
(98.1 %id)
CR613874 adult brain .g 1 to 2202 1 to 1814 exact tiling clone, Suspected internal deletion 1814/1814
(100 %)
3 diff
(99.9 %id)
BX116345 liver and spleen .h 1 to 753 1 to 753 exact tiling clone,   753/754
(99 %)
4 diff
(99.5 %id)
T82134 liver and spleen .h 2 to 311 1 to 311       311/312
(99 %)
16 diff
(94.9 %id)
R16664 liver and spleen .h 2 to 292 1 to 287       287/287
(100 %)
14 diff
(95.2 %id)
AI078435 liver and spleen .h 632 to 979 352 to 5   tiling clone,   348/352
(98 %)
0 diff
(100 %id)
R16665 liver and spleen .h 714 to 979 279 to 12       268/334
(80 %)
0 diff
(100 %id)
DB473358 hippocampus .i 1 to 493 1 to 493   tiling clone,   493/493
(100 %)
0 diff
(100 %id)
CD641095 pooled .i 388 to 1015 1 to 618   tiling clone,   618/716
(86 %)
12 diff
(98.4 %id)
BM547329 ovary (pool of 3) .j 1 to 953 20 to 978 K24X Q77X F85V G86W H87S ... tiling clone,   959/1145
(83 %)
49 diff
(95.8 %id)
BG540922 lung .j 411 to 1119 4 to 704 K24A P25Q K26T Q27G D28Y ...     706/875
(80 %)
31 diff
(96.5 %id)
BM907752 large cell carcinoma, lung .j 414 to 1008 13 to 619 exact     612/1437
(42 %)
18 diff
(98.8 %id)
BQ185821 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 437 to 957 1 to 518   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 518/518
(100 %)
0 diff
(100 %id)
AF308286 breast .j 453 to 1520 1 to 1070   tiling clone,   1070/1070
(100 %)
7 diff
(99.4 %id)
BX504568   .j 494 to 1204 1 to 710   tiling clone,   710/711
(99 %)
2 diff
(99.8 %id)
AA034417 heart .j 500 to 975 1 to 482       479/482
(99 %)
7 diff
(98.6 %id)
CN478570 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 927 to 1444 536 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 518/518
(100 %)
0 diff
(100 %id)
AA053882 heart .j 980 to 1444 465 to 1       465/465
(100 %)
0 diff
(100 %id)
BF694870 muscle (skeletal) .k 1 to 567 9 to 592 G10R D11R V12R V13R I14S ... tiling clone,   587/1211
(48 %)
39 diff
(96.8 %id)
CB164359 Liver .k 361 to 874 1 to 514   tiling clone,   514/514
(100 %)
1 diff
(99.9 %id)
BX294216   .l 1 to 749 1 to 757 V4G Y5V T6N P7A S8V ... tiling clone,   757/834
(90 %)
19 diff
(97.8 %id)
DB494884 hypothalamus .m 1 to 492 1 to 492 exact tiling clone,   492/492
(100 %)
0 diff
(100 %id)
CV360801 head_neck .n-u 1 to 302 304 to 3   tiling clone, Submitted on the opposite strand 302/304
(99 %)
0 diff
(100 %id)
AV725059 hypothalamus .n-u 178 to 804 1 to 626       626/626
(100 %)
38 diff
(94.0 %id)
AV728489 hypothalamus .n-u 178 to 803 1 to 626   tiling clone,   626/626
(100 %)
2 diff
(99.7 %id)
AW898332 nervous_normal .n-u 364 to 802 1 to 438   tiling clone,   438/438
(100 %)
8 diff
(98.2 %id)
BX411854 neuroblastoma .n-u 606 to 1380 783 to 10 G2L F3G G4F H5G Y6P ...     774/783
(98 %)
0 diff
(100 %id)
TI_154050502   .n-u 622 to 1473 955 to 112 G2V F3C G4H H5Y Y6K ... AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 844/996
(84 %)
16 diff
(98.4 %id)
FN099884 breast carcinoma .n-u 674 to 782 107 to 1     Submitted on the opposite strand 107/107
(100 %)
3 diff
(97.2 %id)
BQ007972 Chondrosarcoma, Left Pelvis .n-u 697 to 1396 718 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 700/700
(100 %)
0 diff
(100 %id)
AW969692   .n-u 714 to 1182 92 to 557       466/560
(83 %)
13 diff
(97.7 %id)
BU076634 Pancreas, Purified pancreatic islet .n-u 734 to 1294 1 to 561       561/561
(100 %)
0 diff
(100 %id)
TI_149277879   .n-u 756 to 1587 947 to 118   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 830/1052
(78 %)
31 diff
(97.1 %id)
BP318205 pericardium .n-u 759 to 1342 1 to 584       584/584
(100 %)
6 diff
(99.0 %id)
TI_154099676   .n-u 761 to 1406 735 to 90   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 646/648
(99 %)
6 diff
(99.1 %id)
CK902449 Pancreas, Purified pancreatic islet .n-u 763 to 1360 1 to 599     Submitted on the opposite strand 599/601
(99 %)
6 diff
(99.1 %id)
BQ019220 lung, Metastatic Chondrosarcoma .n-u 787 to 1465 697 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 679/689
(98 %)
0 diff
(100 %id)
AW390324 stomach .n-u 800 to 1014 222 to 6       217/222
(97 %)
0 diff
(100 %id)
BQ019209 lung, Metastatic Chondrosarcoma .n-u 802 to 1465 682 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 664/664
(100 %)
0 diff
(100 %id)
CB160587 Liver .n-u 805 to 1360 1 to 556       556/556
(100 %)
0 diff
(100 %id)
CB160330 Liver .n-u 807 to 1242 1 to 436       436/436
(100 %)
0 diff
(100 %id)
BF515889   .n-u 815 to 1397 600 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 583/583
(100 %)
7 diff
(98.8 %id)
CA414042 Chondrosarcoma Grade II, Left Pelvis .n-u 816 to 1473 676 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 658/658
(100 %)
3 diff
(99.6 %id)
AI720056 colon .n-u 818 to 1398 583 to 3       581/583
(99 %)
0 diff
(100 %id)
AI670810 Kidney .n-u 855 to 1474 624 to 6       619/624
(99 %)
0 diff
(100 %id)
CA441139 Fibrosarcoma .n-u 868 to 1406 557 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 539/539
(100 %)
0 diff
(100 %id)
AW268679 lung, two pooled squamous cell carcinomas .n-u 871 to 1398 530 to 3       528/530
(99 %)
0 diff
(100 %id)
FN110489 breast carcinoma .n-u 880 to 964 84 to 1     Submitted on the opposite strand 84/84
(100 %)
1 diff
(98.9 %id)
BF002229 colon, colon tumor, RER+ .n-u 882 to 1398 517 to 1       517/517
(100 %)
1 diff
(99.9 %id)
AW195755 pooled .n-u 886 to 1473 599 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 589/589
(100 %)
7 diff
(98.9 %id)
AI867849 pooled germ cell tumors .n-u 934 to 1404 473 to 3       471/473
(99 %)
0 diff
(100 %id)
AI682042 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n-u 937 to 1398 470 to 8       463/470
(98 %)
0 diff
(100 %id)
AI672024 pooled germ cell tumors .n-u 937 to 1404 471 to 4       468/471
(99 %)
0 diff
(100 %id)
FN165106 breast carcinoma .n-u 943 to 1056 108 to 1     Submitted on the opposite strand 108/108
(100 %)
6 diff
(94.5 %id)
CK902450 Pancreas, Purified pancreatic islet .n-u 947 to 1458 533 to 22   AAA Submitted on the opposite strand 512/512
(100 %)
1 diff
(99.9 %id)
TI_159723872   .n-u 961 to 1396 517 to 82   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 436/1053
(41 %)
2 diff
(99.9 %id)
CA944576 Human Lung Epithelial cells, lung .n-u 961 to 1396 454 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 436/456
(95 %)
2 diff
(99.6 %id)
AI400941 Prostate .n-u 965 to 1459 503 to 9       495/503
(98 %)
0 diff
(100 %id)
FN125650 breast carcinoma .n-u 979 to 1046 1 to 67       67/83
(80 %)
4 diff
(95.2 %id)
FN157862 breast carcinoma .n-u 979 to 1057 1 to 79       79/79
(100 %)
3 diff
(96.3 %id)
BE670173 carcinoid, lung .n-u 980 to 1473 507 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 494/494
(100 %)
0 diff
(100 %id)
BE646125 Prostate .n-u 982 to 1459 484 to 7       478/485
(98 %)
0 diff
(100 %id)
BU532823 mixed (pool of 40 RNAs) .n-u 988 to 1474 1 to 487       487/495
(98 %)
1 diff
(99.8 %id)
BG978354 colon_ins .n-u 991 to 1263 1 to 271       271/271
(100 %)
11 diff
(96.0 %id)
BX110759 adenocarcinoma, Pancreas .n-u 1002 to 1458 471 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
T62545 lung .n-u 1016 to 1457 456 to 1       456/458
(99 %)
25 diff
(94.6 %id)
AW196438 pooled germ cell tumors .n-u 1023 to 1479 474 to 18       457/474
(96 %)
0 diff
(100 %id)
AA770253   .n-u 1024 to 1404 390 to 10       381/390
(97 %)
0 diff
(100 %id)
BE549571 carcinoid, lung .n-u 1056 to 1588 538 to 6       533/538
(99 %)
0 diff
(100 %id)
AI584045 adenocarcinoma, Pancreas .n-u 1077 to 1459 383 to 1       383/383
(100 %)
2 diff
(99.5 %id)
AA883340 pooled .n-u 1080 to 1474 398 to 4       395/398
(99 %)
0 diff
(100 %id)
BU963810 mixed (pool of 40 RNAs) .n-u 1080 to 1466 1 to 388       388/388
(100 %)
2 diff
(99.5 %id)
BP426125 small intestine .n-u 1081 to 1366 1 to 285     Submitted on the opposite strand 285/285
(100 %)
1 diff
(99.7 %id)
AW243732 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n-u 1094 to 1398 307 to 3       305/307
(99 %)
0 diff
(100 %id)
AW137059   .n-u 1099 to 1473 392 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 375/385
(97 %)
1 diff
(99.8 %id)
DB542130 hippocampus .n-u 1109 to 1585 1 to 477     Submitted on the opposite strand 477/479
(99 %)
1 diff
(99.8 %id)
AA721474 germinal center B cell .n-u 1116 to 1397 294 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 283/283
(100 %)
1 diff
(99.7 %id)
BU958884 mixed (pool of 40 RNAs) .n-u 1121 to 1471 1 to 350       350/389
(89 %)
2 diff
(99.5 %id)
AA483037 Ewing's sarcoma .n-u 1123 to 1397 300 to 26   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 275/275
(100 %)
0 diff
(100 %id)
AI655564 pooled germ cell tumors .n-u 1133 to 1587 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AA724043 pooled .n-u 1162 to 1398 240 to 4       237/240
(98 %)
0 diff
(100 %id)
AI972198 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .n-u 1172 to 1589 421 to 4       418/421
(99 %)
0 diff
(100 %id)
AI915665 pooled .n-u 1175 to 1459 293 to 9       285/293
(97 %)
0 diff
(100 %id)
CN390070 embryonic stem cells, DMSO-treated H9 cellline .n-u 1176 to 1571 1 to 397       397/397
(100 %)
1 diff
(99.8 %id)
AI269187 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n-u 1206 to 1473 278 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 268/268
(100 %)
2 diff
(99.3 %id)
DB565930 hypothalamus .n-u 1277 to 1743 1 to 467   tiling clone, Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
CN284047 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .o-u 1 to 748 1 to 748 exact tiling clone,   748/748
(100 %)
3 diff
(99.6 %id)
BY994732   .p-u 1 to 662 22 to 684 exact tiling clone,   663/685
(96 %)
7 diff
(99.0 %id)
AV728556 hypothalamus .p-u 6 to 639 1 to 634       634/634
(100 %)
4 diff
(99.4 %id)
CD696597 normal nasopharynx .q-u 1 to 547 39 to 583 exact tiling clone,   552/583
(94 %)
6 diff
(99.0 %id)
BF755768 colon .q-u 49 to 444 400 to 6   tiling clone, Submitted on the opposite strand 395/413
(95 %)
0 diff
(100 %id)
AB458221   Gene PPIL4andZC3H12D, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AB458222   Gene PPIL4andZC3H12D, variant not shown       AAA Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored    
AK127932 Spleen Gene PPIL4andZC3H12D, variant not shown       available from FLJ, Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored    
BE141960 head_neck Gene PPIL4andZC3H12D, variant not shown              
BE825577 lung_normal Gene PPIL4andZC3H12D, variant not shown              
BF907096 uterus_tumor Gene PPIL4andZC3H12D, variant not shown         Submitted on the opposite strand    
DB308100 hippocampus Gene PPIL4andZC3H12D, variant not shown              
DA302581 hippocampus Gene PPIL4andZC3H12D, variant not shown       capped      
BX089425   Gene PPIL4andZC3H12D, variant not shown              
BX401527   Gene PPIL4andZC3H12D, variant not shown         Suspected internal deletion, this clone was ignored    
BX401528   Gene PPIL4andZC3H12D, variant not shown         Suspected internal deletion, this clone was ignored    
BX444500 adult brain, brain Gene PPIL4andZC3H12D, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
BX444501 adult brain, brain Gene PPIL4andZC3H12D, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
FN088001 breast carcinoma Gene PPIL4andZC3H12D, variant not shown         Submitted on the opposite strand    
FN108033 breast carcinoma Gene PPIL4andZC3H12D, variant not shown         Submitted on the opposite strand    
AV653275 corresponding non cancerous liver tissue Gene PPIL4andZC3H12D, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AA215652 germinal center B cell Gene PPIL4andZC3H12D, variant not shown              
AA215721 germinal center B cell Gene PPIL4andZC3H12D, variant not shown              
AA279381 germinal center B cell Gene PPIL4andZC3H12D, variant not shown              
AA293891   Gene PPIL4andZC3H12D, variant not shown              
AA398305   Gene PPIL4andZC3H12D, variant not shown              
AA398931   Gene PPIL4andZC3H12D, variant not shown              
AA402053   Gene PPIL4andZC3H12D, variant not shown              
AI688689 colon Gene PPIL4andZC3H12D, variant not shown              
AI688700 colon Gene PPIL4andZC3H12D, variant not shown              
BU076351 Pancreas, Purified pancreatic islet Gene PPIL4andZC3H12D, variant not shown         This clone was ignored    
TI_154055845   Gene PPIL4andZC3H12D, variant not shown       AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS    
AV754980 pituitary tumor Gene PPIL4andZC3H12D, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
CA418740 Chondrosarcoma Grade II, Left Pelvis Gene PPIL4andZC3H12D, variant not shown       AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o-u, .p-u, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI